Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03453242
Other study ID # K 171006J
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date March 2, 2018
Est. completion date July 19, 2019

Study information

Verified date September 2021
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The study of this study is to evaluate the age influence on cortical bone strength properties by two methods:HR-pQCT (HighResolution-peripheral quantitativeComputedTomography) and ultrasound. The main objective consists in the evaluation of the age influence on cortical thickness at 1/3 distal radius measured by US.


Description:

The study of this study is to evaluate the age influence on cortical bone by two methods: HR-pQCT and ultrasound. 84 patients will be measured. The cohort will be: - 21 women less than 70 - 21 women more than 70 - 21 men less than 70 - 21 men more than 70 Measurement will be performed at radius and at tibia (ultra-distal and distal). For all the sites one measurement will be performed by HR-pQCT to get reference values of thickness and BMDs. For the distal positions and additional measurement will be performed by an innovative ultrasound device that estimates cortical thickness and porosity. The participation to the study implies only a participation of one hour from the patient (30min for HR-pQCT measurements, 30 min for US). The main objectives consist in : - evaluating the age influence on cortical thickness at 1/3 distal radius measured by US - evaluating the age influence on cortical thickness at distal tibia measured by US - comparing porosities values measured by US to vBMD obtained by HR-pQCT - comparing cortical thickness values measured by HR-pQCT at 1/3 distal radius position to ultra-distal radus position and to the tibia - comparing vBMD values measured by HRpQCT at 1/3 distal radius position to ultra-distal radius position and to the tibia


Recruitment information / eligibility

Status Terminated
Enrollment 66
Est. completion date July 19, 2019
Est. primary completion date July 19, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - being 18 or older - coming from the rheumatology consultation at Lariboisière Hospital Exclusion Criteria: - BMI > 28 - BMI < 15 - cortisone treatment - recent fracture at non-dominant arm - wound on measuring zone - treatment interfering with bone architecture or bone density : oral of transdermic oestrogenes, bisphosphonates (Alendronate, Risedronate, Zoledronate) or Denosumab during the past 6 months-

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Bone measurement by HR-pQCT and ultrasound
Measurement will be performed at radius and at tibia (ultra-distal and distal). For all the sites one measurement will be performed by HR-pQCT to get reference values of thickness and BMDs. For the distal positions and additional measurement will be performed by an innovative ultrasound device that estimates cortical thickness and porosity.

Locations

Country Name City State
France Cohen-Solal Paris Ile De France

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

References & Publications (3)

Barkmann R, Kantorovich E, Singal C, Hans D, Genant HK, Heller M, Glüer CC. A new method for quantitative ultrasound measurements at multiple skeletal sites: first results of precision and fracture discrimination. J Clin Densitom. 2000 Spring;3(1):1-7. — View Citation

Bochud N, Vallet Q, Bala Y, Follet H, Minonzio JG, Laugier P. Genetic algorithms-based inversion of multimode guided waves for cortical bone characterization. Phys Med Biol. 2016 Oct 7;61(19):6953-6974. Epub 2016 Sep 12. — View Citation

Zebaze RM, Ghasem-Zadeh A, Bohte A, Iuliano-Burns S, Mirams M, Price RI, Mackie EJ, Seeman E. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet. 2010 May 15;375(9727):1729-36. doi: 10.1016/S0140-6736(10)60320-0. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Cortical parameters measurement Cortical thickness at distal radius 1/3 Inclusion time
Secondary Tibia parameters measurement by US Cortical thickness distal 1/2 tibia obtained by US
ultra-distal and 1/3 distal cortical thicknesses obtained by HR-pQCT
ultra-distal and 1/3 distal vBMD obtained by HR-pQCT
Inclusion time
Secondary Tibia parameters measurement by HR-pQCT Cortical thickness distal 1/2 tibia obtained by HR-pQCT
ultra-distal and 1/3 distal cortical thicknesses obtained by HR-pQCT
ultra-distal and 1/3 distal vBMD obtained by HR-pQCT
Inclusion time
Secondary Porosity measurement Ultrasonic porosity obtained by HR-pQCT Inclusion time
Secondary vBMD measurement vBMD obtained by HR-pQCT Inclusion time
Secondary Cortical parameters measurement 1/3 distal cortical thicknesses obtained by HR-pQCT Inclusion time
Secondary Thicknesses measurement Ultra-distal thicknesses obtained by HR-pQCT Inclusion time
Secondary Ultra-distal vBMD measurement Ultra-distal vBMD and third distal obtained by HR-pQCT Inclusion time